Mercator MedSystems
San Leandro, US · Delaware corporation · 2 known investors
Mercator MedSystems develops catheter-based Micro-Infusion technologies, including the Bullfrog Micro-Infusion Device, for the local delivery of pharmacologic and biologic agents to the peripheral vasculature. The medical device company runs clinical studies in deep vein thrombosis and below-the-knee peripheral arterial disease, with applications in cardiovascular treatment and denervation for hypertension.
Founders & leadership
Board

Investors · 2
Reported raises · per SEC filings
Form D private placements$14.3M disclosed across 1 round · 2018
▶$14.3MraisedJun 2019 · 25 investors · Other Health CareRule 506(b)
- Trent ReutimanExecutive Officer, Director
- Stephen BakerExecutive Officer
- Kirk SewardExecutive Officer
- Charles CrockerDirector
- Ned ScheetzDirector
- Doug WallDirector
- Offering amount
- $15M
- Amount sold
- $14.3M
- First sale
- May 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 4
by search overlapCompanies competing with Mercator MedSystems for the same Google search keywords, organic and paid, via search-intersection analysis.
Non-dilutive funding · 6 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase ISTTR | 2021 | $299.7K |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2013 | $2M |
| National Institutes of Health (NIH)National Institutes of Health | Phase IISTTR | 2011 | $1.1M |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2010 | $217.4K |
| National Institutes of Health (NIH)National Institutes of Health | Phase ISTTR | 2009 | $218.1K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2007 | $194.2K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- What does Mercator MedSystems do?
- Mercator MedSystems develops catheter-based Micro-Infusion technologies, including the Bullfrog Micro-Infusion Device, for the local delivery of pharmacologic and biologic agents to the peripheral vasculature. The medical device company runs clinical studies in deep vein thrombosis and below-the-knee peripheral arterial disease, with applications in cardiovascular treatment and denervation for hypertension.
- Who founded Mercator MedSystems?
- Mercator MedSystems was founded by Kirk P. Seward.
- Who are Mercator MedSystems's investors?
- Mercator MedSystems's investors include Aphelion Capital, Medvest Capital.
- How much funding has Mercator MedSystems raised?
- Mercator MedSystems has disclosed $14.3M raised across 1 round.
- Where is Mercator MedSystems headquartered?
- Mercator MedSystems is headquartered in San Leandro, US.

